An intervention to stop tobacco use among patients suspected of tuberculosis (TB)
Completed
- Conditions
- Tuberculosis and tobacco useInfections and InfestationsRespiratory tuberculosis, not confirmed bacteriologically or histologically
- Registration Number
- ISRCTN08829879
- Lead Sponsor
- International Development Research Centre (IDRC) (Canada)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1100
Inclusion Criteria
In each health centre, we will approach adult patients (greater than or equal to 18 years, either sex), who cough for three or more weeks and are therefore suspected and screened for pulmonary tuberculosis.
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Point abstinence at 4 weeks: the proportion of trial participants who have completely given up all forms of nicotine use at four weeks after the completion of NRT, bupropion and/or brief counselling therapy<br>2. Continuous abstinence up to 6 months: proportion of trial participants who remained abstinent from 4 weeks onwards up to six months<br>3. We will also measure tobacco use, e.g. number of cigarettes smoked per day to estimate any reduction in tobacco use secondary to the intervention
- Secondary Outcome Measures
Name Time Method 1. Incidence of various adverse affects secondary to therapy<br>2. Economic outcomes assessed in terms of healthcare cost to get one person to stop smoking at four weeks. Healthcare cost will include the treatment cost, the average duration of health professionals' time spent with the patients during assessment, advice and counselling.<br>3. Process outcomes include: <br>3.1. The proportion of tobacco users who decide to quit and registered to receive 'five steps to quit' intervention<br>3.2. The proportion of people registered who continue follow-up for the full period planned